Investigating the mode of action compounds play within the matrix preparation to explain how herbal medicine can actually improve patients’ condition. Our formulations are composed of a multitude of different bioactive constituents present in the form of dry material. By making decoction preparations, these constituents work altogether through various interactive chemical bindings to activate the signaling pathways and compensatory mechanisms of cells in order to restore the dysfunctional status of the affected organ(s). It is of importance to decipher the types of compounds interactions as well to address their pharmacologic effects (i.e. from cellular to physiological levels) to define the unique therapeutic effects herbs which are playing within the patient body affected by infertilities and gynecologic neoplasms.
To support our products’ claim and approval in the biomedical field, the research platform incorporates analytical studies to confirm the identity, concentration, and consistency of bioactive constituents in our single herb and between batches. The potency of each constituent is determined by biological assays and standard measurements. The biological function of compounds is further assessed by nonclinical safety experiments, such as those conducted on human cell culture and tissues. The therapeutic index of our products is evaluated by in vivo pharmacological studies using dose-response relationship trials. Our effort is directed at assessing the infertility biomarkers to assess the menstrual cycle which is important for improving the success rate of pregnancy that current funded technologies and medical procedures are striving to fulfill customers’ demand: improving the conception rate and sustaining a healthy birth for infertile couples.
Our effort probes infertility biomarkers in the menstrual cycle to fulfill customers’ demand: improving the conception rate and sustaining a healthy birth among infertile couples. In addition, our effort investigates gynecologic neoplasm biomarkers in selective uterine, ovarian and cervical tumors and cancers for increasing the survival rate and quality of life among women.